Similar articles

• Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.

  Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):677-85. doi: 10.1016/s0360-3016(02)02977-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377318 Clinical Trial.
• Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: will more prove better?

  Schellhammer PF. Schellhammer PF. Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):489-90. doi: 10.1016/s0360-3016(98)00090-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9635693 No abstract available.
• Commentary on a multi-institutional analysis of external beam radiotherapy for T1-T2 prostate cancer: "love the one you're with" and "do the right thing".

  Roach M 3rd. Roach M 3rd. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):907-9. doi: 10.1016/s0360-3016(03)01619-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 14575819 No abstract available.
• Planning target volume definition in dose-escalation studies.

  Vordermark D, Flentje M. Vordermark D, et al. Front Radiat Ther Oncol. 2002;36:16-24. doi: 10.1159/000061324. Front Radiat Ther Oncol. 2002. PMID: 11842747 Review. No abstract available.
• The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?

  Levitt SH, Khan FM. Levitt SH, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):871-9. doi: 10.1016/s0360-3016(01)01720-5. Int J Radiat Oncol Biol Phys. 2001. PMID: 11704309 Review.